QTREX Quantum Ltd. (QTEX) awards 550,000-share RSU package to its CFO

Rhea-AI Filing Summary

Tehila Yafit reported acquisition or exercise transactions in this Form 4 filing.

QTREX Quantum Ltd. granted Chief Financial Officer Tehila Yafit 550,000 Ordinary Shares as a compensation award at $0.0000 per share, increasing her direct holdings to 1,420,000 shares. The award is structured as Restricted Share Units that vest, including 183,334 RSUs on July 1, 2027, with the remaining RSUs vesting on a quarterly basis over the following two years.

Insider Trade Summary

Net Buyer: 550,000 shares

Net Buy 1 txn

Insider Tehila Yafit

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares F1	550,000	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 1,420,000 shares (Direct)

Footnotes (1)

1. F1. The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years following the first vesting event.

Key Figures

RSU/Share Grant Size: 550000.0000 shares Grant Price: $0.0000 per share Post-transaction Holdings: 1420000.0000 shares +2 more

5 metrics

RSU/Share Grant Size 550000.0000 shares Ordinary Shares granted to CFO Tehila Yafit on 2026-07-06

Grant Price $0.0000 per share Reported transaction price per Ordinary Share for the award

Post-transaction Holdings 1420000.0000 shares Total Ordinary Shares held directly by CFO after the grant

Initial Vesting Tranche 183334 RSUs RSUs scheduled to vest on July 1, 2027 under the 2019 Plan

Subsequent Vesting Period 2 years Remaining RSUs vest quarterly over two years after first vest date

Key Terms

Restricted Share Units, 2019 Plan, vesting, Grant, award, or other acquisition

4 terms

Restricted Share Units financial

"The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s 2019 Plan"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

2019 Plan financial

"RSUs were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan"

vesting financial

"183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Grant, award, or other acquisition financial

"Transaction code A is described as Grant, award, or other acquisition"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/14/2026 - 05:41 PM Accepted by SEC EDGAR 07/14/2026 - 05:40 PM Learn about SEC filing dates

FAQ

What insider transaction did QTREX Quantum (QTEX) disclose for CFO Tehila Yafit?

QTREX Quantum disclosed that CFO Tehila Yafit received a grant of 550,000 Ordinary Shares as a compensation award at $0.0000 per share. The grant is structured as RSUs with a multi-year vesting schedule tied to continued service.

How many QTEX shares does CFO Tehila Yafit hold after this Form 4 transaction?

Following the grant, CFO Tehila Yafit directly holds 1,420,000 Ordinary Shares of QTREX Quantum Ltd. This figure reflects her position after receiving the 550,000-share RSU-based award reported in the Form 4 filing.

What is the vesting schedule for QTREX Quantum (QTEX) CFO Yafit’s RSU award?

The RSUs will vest in stages: 183,334 RSUs vest on July 1, 2027, and the remaining RSUs vest on a quarterly basis over the subsequent two years. This links the award’s value to her ongoing tenure with the company.

Did CFO Tehila Yafit pay cash for the 550,000 QTEX shares she acquired?

No. The 550,000 Ordinary Shares were granted at a price of $0.0000 per share as a compensation award, reported under transaction code A for a grant or award acquisition, rather than as an open-market share purchase.

Under which plan were QTREX Quantum (QTEX) CFO Yafit’s RSUs granted?

The Restricted Share Units were granted under Qtrex Quantum Ltd.'s 2019 Plan. The footnote explains that these RSUs follow the specified vesting schedule starting July 1, 2027, and continuing with quarterly vesting over the next two years.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tehila Yafit

(Last) (First) (Middle)

2 HA-TIDHAR ST.

(Street)

RA'ANANA 4366504

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
QTREX Quantum Ltd. [ QTEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	07/06/2026		A		550,000(1)	A	$0	1,420,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years following the first vesting event.

	/s/ Yafit Tehila	07/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)